DE60319951D1 - Aminocyclische substituierte pyrrolopyrimidinderivate und pyrrolopyridinderivate - Google Patents

Aminocyclische substituierte pyrrolopyrimidinderivate und pyrrolopyridinderivate

Info

Publication number: DE60319951D1
Authority: DE; Germany
Prior art keywords: derivatives; pyrrolopyrimidin; aminocyclic; substituted; pyrrolopyridine
Prior art date: 2002-12-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE60319951T

Other languages

English (en)

Other versions

DE60319951T2 (de

Inventor

Atsuro Nakazato

Taketoshi Okubo

Dai Nozawa

Mikako Yamaguchi

Tomoko Tamita

Ludo E J Kennis

Bruyn Marcel F L De

Jean-Pierre A M Bongartz

Den Keybus Frans M A Van

Roosbroeck Yves E M Van

Marcel G M Luyckx

Robert J M Hendrickx

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Taisho Pharmaceutical Co Ltd

Original Assignee

Taisho Pharmaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-12-26

Filing date

2003-12-24

Publication date

2008-05-08

2003-12-24 Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd

2008-05-08 Application granted granted Critical

2008-05-08 Publication of DE60319951D1 publication Critical patent/DE60319951D1/de

2009-05-20 Publication of DE60319951T2 publication Critical patent/DE60319951T2/de

2023-12-25 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Psychiatry (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Addiction (AREA)
Psychology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Dermatology (AREA)
Hospice & Palliative Care (AREA)
Immunology (AREA)
Nutrition Science (AREA)
Vascular Medicine (AREA)
Rheumatology (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Saccharide Compounds (AREA)

DE60319951T 2002-12-26 2003-12-24 Aminocyclische substituierte pyrrolopyrimidinderivate und pyrrolopyridinderivate Expired - Lifetime DE60319951T2 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2002383667		2002-12-26
JP2002383667		2002-12-26
PCT/JP2003/016598 WO2004058767A1 (en)	2002-12-26	2003-12-24	Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group

Publications (2)

Publication Number	Publication Date
DE60319951D1 true DE60319951D1 (de)	2008-05-08
DE60319951T2 DE60319951T2 (de)	2009-05-20

Family

ID=32677471

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DE60319951T Expired - Lifetime DE60319951T2 (de)	2002-12-26	2003-12-24	Aminocyclische substituierte pyrrolopyrimidinderivate und pyrrolopyridinderivate
DE60327477T Expired - Lifetime DE60327477D1 (de)	2002-12-26	2003-12-24	Pyrrolopyrimidin- und Pyrrolopyridin-Derivate substituiert durch eine cyklische Amingruppe

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DE60327477T Expired - Lifetime DE60327477D1 (de)	2002-12-26	2003-12-24	Pyrrolopyrimidin- und Pyrrolopyridin-Derivate substituiert durch eine cyklische Amingruppe

Country Status (23)

Country	Link
US (3)	US20050209253A1 (de)
EP (2)	EP1467997B8 (de)
JP (1)	JP4181126B2 (de)
KR (2)	KR100808756B1 (de)
CN (1)	CN1692115A (de)
AR (1)	AR042667A1 (de)
AT (2)	ATE390426T1 (de)
AU (1)	AU2003292550B8 (de)
BR (1)	BR0307587A (de)
CA (1)	CA2485556C (de)
CL (1)	CL2003002762A1 (de)
DE (2)	DE60319951T2 (de)
EA (1)	EA200401060A1 (de)
ES (2)	ES2325596T3 (de)
HR (1)	HRP20040724A2 (de)
MX (1)	MXPA04008081A (de)
MY (1)	MY141200A (de)
NO (1)	NO20043508L (de)
PL (1)	PL371810A1 (de)
TW (1)	TWI270549B (de)
UA (1)	UA77265C2 (de)
WO (1)	WO2004058767A1 (de)
ZA (1)	ZA200405982B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1701961A1 (de) *	2004-01-06	2006-09-20	Taisho Pharmaceutical Co., Ltd	Mit einer cyclischen aminogruppe substituierte thienopyrimidin- und thienopyridinderivate
RU2367663C2 (ru) *	2004-01-06	2009-09-20	Тайсо Фармасьютикал Ко., Лтд.	Производные пирролопиримидина и пирролотриазина
CN1910187A (zh)	2004-01-06	2007-02-07	大正制药株式会社	三氮杂－环戊烷并[cd]茚衍生物
JP2007526906A (ja) *	2004-03-05	2007-09-20	大正製薬株式会社	ピロロピリミジン誘導体
EP1781652A1 (de) *	2004-06-25	2007-05-09	Taisho Pharmaceutical Co., Ltd	Pyrrolopyrimidin und pyrrolopyridinderivate substituiert durch tetrahydropyridin als crf-antagonisten
JP2007161585A (ja) *	2004-06-25	2007-06-28	Taisho Pharmaceut Co Ltd	環状アミノ基で置換されているピロロピリミジン及びピロロピリジン誘導体
DE102004042607A1 (de) *	2004-09-03	2006-03-09	Bayer Healthcare Ag	Substituierte Phenylaminothiazole und ihre Verwendung
DE102006042143A1 (de) *	2006-09-08	2008-03-27	Bayer Healthcare Aktiengesellschaft	Neue substituierte Bipyridin-Derivate und ihre Verwendung
DE102006056739A1 (de) *	2006-12-01	2008-06-05	Bayer Healthcare Ag	Substituierte 4-Amino-3,5-dicyano-2-thiopyridine und ihre Verwendung
DE102006056740A1 (de) *	2006-12-01	2008-06-05	Bayer Healthcare Ag	Cyclisch substituierte 3,5-Dicyano-2-thiopyridine und ihre Verwendung
US8969514B2 (en)	2007-06-04	2015-03-03	Synergy Pharmaceuticals, Inc.	Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
WO2008151257A2 (en)	2007-06-04	2008-12-11	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
DE102007035367A1 (de) *	2007-07-27	2009-01-29	Bayer Healthcare Ag	Substituierte Aryloxazole und ihre Verwendung
DE102007036076A1 (de)	2007-08-01	2009-02-05	Bayer Healthcare Aktiengesellschaft	Dipeptoid-Produgs und ihre Verwendung
DE102007061763A1 (de) *	2007-12-20	2009-06-25	Bayer Healthcare Ag	Substituierte azabicyclische Verbindungen und ihre Verwendung
DE102007061764A1 (de) *	2007-12-20	2009-06-25	Bayer Healthcare Ag	Anellierte Cyanopyridine und ihre Verwendung
DE102008013587A1 (de) *	2008-03-11	2009-09-17	Bayer Schering Pharma Aktiengesellschaft	Heteroaryl-substituierte Dicyanopyridine und ihre Verwendung
CL2009001152A1 (es)	2008-05-13	2009-10-16	Array Biopharma Inc	Compuestos derivados de n-(4-(cicloalquilo nitrogenado-1-il)-1h-pirrolo[2,3-b]piridin-3-il)amida, inhibidores de cinasa; proceso de preparacion; composicion farmaceutica; y su uso para el tratamiento de una enfermedad proliferativa.
CA2726020C (en) *	2008-05-29	2016-08-16	Bayer Schering Pharma Aktiengesellschaft	2-alkoxy-substituted dicyanopyridines and use thereof
WO2009149279A2 (en)	2008-06-04	2009-12-10	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2730603C (en)	2008-07-16	2019-09-24	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
DE102008062567A1 (de)	2008-12-16	2010-06-17	Bayer Schering Pharma Aktiengesellschaft	Dipeptoid-Prodrugs und ihre Verwendung
DE102009006602A1 (de) *	2009-01-29	2010-08-05	Bayer Schering Pharma Aktiengesellschaft	Alkylamino-substituierte Dicyanopyridine und deren Aminosäureester-Prodrugs
DE102010030688A1 (de)	2010-06-30	2012-01-05	Bayer Schering Pharma Aktiengesellschaft	Substituierte Dicyanopyridine und ihre Verwendung
US20120058983A1 (en)	2010-09-02	2012-03-08	Bayer Pharma Aktiengesellschaft	Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension
BR112013023266B8 (pt)	2011-03-15	2021-04-06	L Livermore Nat Security Llc	inibidores da girase tricíclicos
EP2970384A1 (de)	2013-03-15	2016-01-20	Synergy Pharmaceuticals Inc.	Agonisten der guanylatcyclase und deren verwendungen
WO2014151200A2 (en)	2013-03-15	2014-09-25	Synergy Pharmaceuticals Inc.	Compositions useful for the treatment of gastrointestinal disorders
AU2014253275B2 (en)	2013-04-11	2018-10-18	F. Hoffmann-La Roche Ag	BACE1 inhibitors
PL2991988T3 (pl) *	2013-05-02	2017-10-31	Hoffmann La Roche	Pochodne pirolo[2,3-d]pirymidyny jako agoniści receptora cb2
CN114829362A (zh) *	2019-12-10	2022-07-29	成都倍特药业股份有限公司	一种可用作shp2抑制剂的含氮杂原子的六元并五元芳环衍生物
CN114646700B (zh) *	2022-03-01	2023-10-20	浙江国邦药业有限公司	一种（s）-吡咯烷-2-甲腈盐酸盐的检测方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL176526B1 (pl)	1992-12-17	1999-06-30	Pfizer	Pirolopirymidyny jako związki o działaniu antagonistów czynnika uwalniającego kortykotropinę
US5646152A (en)	1994-06-15	1997-07-08	Pfizer Inc.	Methods of administering CRF antagonists
JP2891544B2 (ja)	1994-06-16	1999-05-17	ファイザー・インコーポレーテッド	ピラゾロおよびピロロピリジン類
WO1998042699A1 (en)	1997-03-26	1998-10-01	Taisho Pharmaceutical Co., Ltd.	4-tetrahydropyridylpyrimidine derivatives
WO2000053604A1 (en)	1999-03-11	2000-09-14	Taisho Pharmaceutical Co., Ltd.	Carbamoyl tetrahydropyridine derivatives
AR028782A1 (es) *	2000-07-05	2003-05-21	Taisho Pharmaceutical Co Ltd	Derivados heterociclicos tetrahidropiridino o piperidino
CN1910187A (zh) *	2004-01-06	2007-02-07	大正制药株式会社	三氮杂－环戊烷并[cd]茚衍生物

2003
- 2003-12-23 TW TW092136594A patent/TWI270549B/zh not_active IP Right Cessation
- 2003-12-23 AR ARP030104818A patent/AR042667A1/es unknown
- 2003-12-24 CN CNA2003801004264A patent/CN1692115A/zh active Pending
- 2003-12-24 US US10/504,981 patent/US20050209253A1/en not_active Abandoned
- 2003-12-24 AU AU2003292550A patent/AU2003292550B8/en not_active Ceased
- 2003-12-24 EP EP03768186A patent/EP1467997B8/de not_active Expired - Lifetime
- 2003-12-24 ES ES06019987T patent/ES2325596T3/es not_active Expired - Lifetime
- 2003-12-24 BR BR0307587-7A patent/BR0307587A/pt not_active IP Right Cessation
- 2003-12-24 CA CA002485556A patent/CA2485556C/en not_active Expired - Fee Related
- 2003-12-24 WO PCT/JP2003/016598 patent/WO2004058767A1/en not_active Ceased
- 2003-12-24 DE DE60319951T patent/DE60319951T2/de not_active Expired - Lifetime
- 2003-12-24 ES ES03768186T patent/ES2302949T3/es not_active Expired - Lifetime
- 2003-12-24 UA UA20040907464A patent/UA77265C2/uk unknown
- 2003-12-24 AT AT03768186T patent/ATE390426T1/de not_active IP Right Cessation
- 2003-12-24 HR HR20040724A patent/HRP20040724A2/hr not_active Application Discontinuation
- 2003-12-24 KR KR1020067025000A patent/KR100808756B1/ko not_active Expired - Fee Related
- 2003-12-24 EP EP06019987A patent/EP1787992B1/de not_active Expired - Lifetime
- 2003-12-24 DE DE60327477T patent/DE60327477D1/de not_active Expired - Lifetime
- 2003-12-24 JP JP2004562918A patent/JP4181126B2/ja not_active Expired - Fee Related
- 2003-12-24 AT AT06019987T patent/ATE430151T1/de not_active IP Right Cessation
- 2003-12-24 MX MXPA04008081A patent/MXPA04008081A/es active IP Right Grant
- 2003-12-24 EA EA200401060A patent/EA200401060A1/ru unknown
- 2003-12-24 KR KR1020047013348A patent/KR100688395B1/ko not_active Expired - Fee Related
- 2003-12-24 PL PL03371810A patent/PL371810A1/xx not_active Application Discontinuation
- 2003-12-24 MY MYPI20034990A patent/MY141200A/en unknown
- 2003-12-26 CL CL200302762A patent/CL2003002762A1/es unknown
2004
- 2004-07-27 ZA ZA200405982A patent/ZA200405982B/en unknown
- 2004-08-23 NO NO20043508A patent/NO20043508L/no not_active Application Discontinuation
2008
- 2008-04-21 US US12/106,873 patent/US7932259B2/en not_active Expired - Fee Related
2010
- 2010-11-22 US US12/951,556 patent/US8455511B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
KR20040111369A (ko)	2004-12-31
EP1467997A1 (de)	2004-10-20
EA200401060A1 (ru)	2005-02-24
PL371810A1 (en)	2005-06-27
CL2003002762A1 (es)	2005-04-08
KR100688395B1 (ko)	2007-03-02
NO20043508L (no)	2004-10-07
WO2004058767A1 (en)	2004-07-15
US20080287397A1 (en)	2008-11-20
DE60319951T2 (de)	2009-05-20
DE60327477D1 (de)	2009-06-10
US8455511B2 (en)	2013-06-04
ATE390426T1 (de)	2008-04-15
AR042667A1 (es)	2005-06-29
US7932259B2 (en)	2011-04-26
TW200505921A (en)	2005-02-16
HRP20040724A2 (en)	2004-10-31
ES2302949T3 (es)	2008-08-01
AU2003292550B2 (en)	2006-09-21
CN1692115A (zh)	2005-11-02
JP4181126B2 (ja)	2008-11-12
JP2005539090A (ja)	2005-12-22
TWI270549B (en)	2007-01-11
UA77265C2 (en)	2006-11-15
EP1467997B1 (de)	2008-03-26
US20050209253A1 (en)	2005-09-22
EP1467997B8 (de)	2008-08-27
ES2325596T3 (es)	2009-09-09
MXPA04008081A (es)	2004-11-26
EP1787992A1 (de)	2007-05-23
ATE430151T1 (de)	2009-05-15
KR100808756B1 (ko)	2008-02-29
CA2485556A1 (en)	2004-07-15
BR0307587A (pt)	2005-02-01
EP1787992B1 (de)	2009-04-29
US20110130364A1 (en)	2011-06-02
KR20060128063A (ko)	2006-12-13
AU2003292550B8 (en)	2006-11-09
ZA200405982B (en)	2005-09-02
MY141200A (en)	2010-03-31
CA2485556C (en)	2006-01-10
AU2003292550A1 (en)	2004-07-22

Publication	Publication Date	Title
DE60319951D1 (de)	2008-05-08	Aminocyclische substituierte pyrrolopyrimidinderivate und pyrrolopyridinderivate
DE60326611D1 (de)	2009-04-23	N und dergleichen
ATE478870T1 (de)	2010-09-15	Spiroindolinpiperidinderivate
DK1556385T3 (da)	2010-06-14	Heterocyclocarboxamid-derivater
DE60330372D1 (de)	2010-01-14	Indol-3-schwefelderivate
ATE467631T1 (de)	2010-05-15	Chinuclidinamidderivate
NO20041975L (no)	2005-07-16	Bicyklisk oksopyridin og oksopyrimidinderivater
ATE438644T1 (de)	2009-08-15	Chinazolinderivate
IS7720A (is)	2005-03-01	Píperidín-N-oxíð-afleiður
DK2248807T3 (da)	2013-08-26	N-Phenyl-2-pyrimidinaminderivater
IS2599B (is)	2010-04-15	3-fenýlsúlfónýl-8-píperasín-1-ýl-kínólín og lyfjafræðilega viðurkenndar afleiður þess
DK1611131T3 (da)	2011-01-17	Pyrazolopyridin-derivater
CY2014018I2 (el)	2015-12-09	Kαρβαμιδο - υποκατεστημενες πυραζολοπυριδινες
ATE319451T1 (de)	2006-03-15	Tetrahydrochinolin-derivate
DK3384931T3 (da)	2019-09-16	Superfin formoterolformulering
ATE312827T1 (de)	2005-12-15	3-substituierte-4-pyrimidonderivate
DE60311101D1 (de)	2007-02-22	7,8,9,10-tetrahydro-6h-azepino, 6,7,8,9-tetrahydro-pyrido und 2,3-dihydro-2h-pyrrolo (2,1-b)-chinazolinon-derivate
ATE512148T1 (de)	2011-06-15	Pyrazolo- und imidazopyrimidinderivate
DE60307512D1 (de)	2006-09-21	3h-chinazoline -4-on derivaten
EP1585519A4 (de)	2009-09-23	Hochkonzentrierte formulierungen vonopioiden und opiod-derivaten
ATE423771T1 (de)	2009-03-15	Tetrahydrochinolinderivate
DE60223031D1 (de)	2007-11-29	Arylpiperazin gebundene tetrahydroindolonderivate
DE50306277D1 (de)	2007-02-22	4-alkyl-/4-alkenyl-/4-alkinylmethyl/-1-arylcyclohexylamin-derivate
DK1392670T3 (da)	2005-08-08	Substituerede C-furan-2-yl-methylamin- og C-thiophen-2-yl-methylamin-derivater
DE60202381D1 (de)	2005-01-27	Paroxetin-n-formyl-derivate

Legal Events

Date	Code	Title	Description
2009-02-19	8381	Inventor (new situation)	Inventor name: NAKAZATO, ATSURO, TOKYO 170-8633, JP Inventor name: OKUBO, TAKETOSHI, TOKYO 170-8633, JP Inventor name: NOZAWA, DAI, TOKYO 170-8633, JP Inventor name: YAMAGUCHI, MIKAKO, TOKYO 170-8633, JP Inventor name: TAMITA, TOMOKO, TOKYO 170-8633, JP Inventor name: KENNIS, LUDO E.J., 2340 BEERSE, BE Inventor name: DE BRUYN, MARCEL F. L., 2340 BEERSE, BE Inventor name: BONGARTZ, JEAN-PIERRE A. M., 2340 BEERSE, BE Inventor name: VAN DEN KEYBUS, FRANS M. A., 2340 BEERSE, BE Inventor name: VAN ROOSBROECK, YVES E. M., 2340 BEERSE, BE Inventor name: LUYCKX, MARCEL G. M., 2340 BEERSE, BE Inventor name: HENDRICKX, ROBERT J. M., 2340 BEERSE, BE
2009-04-16	8364	No opposition during term of opposition

Date

Code

Title

Description

2009-02-19

8381

Inventor (new situation)

Inventor name: NAKAZATO, ATSURO, TOKYO 170-8633, JP

Inventor name: OKUBO, TAKETOSHI, TOKYO 170-8633, JP

Inventor name: NOZAWA, DAI, TOKYO 170-8633, JP

Inventor name: YAMAGUCHI, MIKAKO, TOKYO 170-8633, JP

Inventor name: TAMITA, TOMOKO, TOKYO 170-8633, JP

Inventor name: KENNIS, LUDO E.J., 2340 BEERSE, BE

Inventor name: DE BRUYN, MARCEL F. L., 2340 BEERSE, BE

Inventor name: BONGARTZ, JEAN-PIERRE A. M., 2340 BEERSE, BE

Inventor name: VAN DEN KEYBUS, FRANS M. A., 2340 BEERSE, BE

Inventor name: VAN ROOSBROECK, YVES E. M., 2340 BEERSE, BE

Inventor name: LUYCKX, MARCEL G. M., 2340 BEERSE, BE

Inventor name: HENDRICKX, ROBERT J. M., 2340 BEERSE, BE

2009-04-16

8364

No opposition during term of opposition